Presentation Information
[Pj-047-4]Fatigue, depression, and QOL changes with continuous administration of Siponimod
Atsuko Katsumoto1, Wakiro Sato2,3, Yowei Lin1, Tomoko Okamoto1, Takashi Yamamura3, Yuji Takahashi1 (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Section of research and development strategy, Translational Medical Center, National Center of Neurology and Psychiatry, Japan, 3.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)